Safety Trial of Naproxen Sodium/ Diphenhydramine
NCT01365052
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
326
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Interventions
DRUG:
Naproxen sodium 440 mg/DPH 50 mg (BAY98-7111)
DRUG:
Placebo
Sponsor
Bayer